140 related articles for article (PubMed ID: 1748979)
1. Prognostic factors in dogs with lymphoma and associated hypercalcemia.
Rosenberg MP; Matus RE; Patnaik AK
J Vet Intern Med; 1991; 5(5):268-71. PubMed ID: 1748979
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma.
Wang SL; Lee JJ; Liao AT
Vet J; 2015 Jul; 205(1):69-73. PubMed ID: 26004824
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma.
Keller ET; MacEwen EG; Rosenthal RC; Helfand SC; Fox LE
J Vet Intern Med; 1993; 7(5):289-95. PubMed ID: 8263847
[TBL] [Abstract][Full Text] [Related]
4. Vasovagal tonus index (VVTI) as an indirect assessment of remission status in canine multicentric lymphoma undergoing multi-drug chemotherapy.
Pecceu E; Stebbing B; Martinez Pereira Y; Handel I; Culshaw G; Hodgkiss-Geere H; Lawrence J
Vet Res Commun; 2017 Dec; 41(4):249-256. PubMed ID: 28791606
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic responses in dogs with lymphosarcoma and hypercalcemia.
Weller RE; Theilen GH; Madewell BR
J Am Vet Med Assoc; 1982 Nov; 181(9):891-3. PubMed ID: 6897239
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the clinical outcome of hypercalcemia of malignancy and concurrent azotemia in dogs with lymphoma.
Strumpf AA; Selmic L; Husbands B
J Vet Intern Med; 2024; 38(1):308-315. PubMed ID: 38131263
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015).
Chan CM; Frimberger AE; Moore AS
Vet Dermatol; 2018 Apr; 29(2):154-e59. PubMed ID: 28983988
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic hypercalcemia.
Bergman PJ
Top Companion Anim Med; 2012 Nov; 27(4):156-8. PubMed ID: 23415382
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study.
Baskin CR; Couto CG; Wittum TE
J Am Anim Hosp Assoc; 2000; 36(5):404-9. PubMed ID: 10997515
[TBL] [Abstract][Full Text] [Related]
10. Actinomycin D for reinduction of remission in dogs with resistant lymphoma.
Moore AS; Ogilvie GK; Vail DM
J Vet Intern Med; 1994; 8(5):343-4. PubMed ID: 7837110
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
12. Multiple metaphyseal involvement of a thymic lymphoma associated with hypercalcemia in a puppy.
Barthez PY; Davis CR; Pool RR; Hornof WJ; Morgan JP
J Am Anim Hosp Assoc; 1995; 31(1):82-5. PubMed ID: 7820770
[TBL] [Abstract][Full Text] [Related]
13. Patient characteristics, prognostic factors and outcome of dogs with high-grade primary mediastinal lymphoma.
Moore EL; Vernau W; Rebhun RB; Skorupski KA; Burton JH
Vet Comp Oncol; 2018 Mar; 16(1):E45-E51. PubMed ID: 28660709
[TBL] [Abstract][Full Text] [Related]
14. Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma?
Hahn KA; Richardson RC; Teclaw RF; Cline JM; Carlton WW; DeNicola DB; Bonney PL
J Vet Intern Med; 1992; 6(1):3-10. PubMed ID: 1548624
[TBL] [Abstract][Full Text] [Related]
15. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.
Siedlecki CT; Kass PH; Jakubiak MJ; Dank G; Lyons J; Kent MS
Can Vet J; 2006 Jan; 47(1):52-9. PubMed ID: 16536229
[TBL] [Abstract][Full Text] [Related]
17. Treatment of canine non-indolent T cell lymphoma using the VELCAP-TSC protocol: A retrospective evaluation of 70 dogs (2003-2013).
Goodman IH; Moore AS; Frimberger AE
Vet J; 2016 May; 211():39-44. PubMed ID: 27017053
[TBL] [Abstract][Full Text] [Related]
18. Rectal lymphoma in 11 dogs: a retrospective study.
Van den Steen N; Berlato D; Polton G; Dobson J; Stewart J; Maglennon G; Hayes AM; Murphy S
J Small Anim Pract; 2012 Oct; 53(10):586-91. PubMed ID: 22882127
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of parathyroid hormone-related protein in dogs with potential disorders of calcium metabolism.
Mellanby RJ; Craig R; Evans H; Herrtage ME
Vet Rec; 2006 Dec; 159(25):833-8. PubMed ID: 17172477
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
